Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 6;10:16584. doi: 10.1038/s41598-020-73523-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

ROC curve analysis of the altered mRNA, lncRNA, and miRNA candidates in normal cervical and adenocarcinoma tissues. (A) ROC analysis of single VIL1, HNF1A-AS1, MIR194-2HG, SSTR5-AS1, miR-192-5p, and miR-194-5p detection for cervical adenocarcinoma diagnosis. (B) ROC analysis of the logit model with miR-192-5p/HNF1A-AS1/VIL1 panel on 57 normal cervical and 141 adenocarcinoma tissue samples. (C) ROC analysis of miR-192-5p/HNF1A-AS1/VIL1 panel and TCT test in 166 patients who have received TCT tests. (D) ROC analysis of combination of the miR-192-5p/HNF1A-AS1/VIL1 panel and TCT tests on 57 normal cervical and 109 adenocarcinoma tissue samples.